Search Within

Wei-Chu Victoria Lai

Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
  3. Editorial (2)
Groups
  1. Department of Medicine (59)
  2. Solid Tumor Oncology Division (59)
  3. Thoracic Oncology (59)
  4. GSK Faculty (40)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (36)

More Groups

People
  1. Charles Rudin (34)
  2. Natasha Rekhtman (20)
  3. Jacklynn Egger (17)
  4. Alexander Drilon (15)
  5. Bob Li (15)
  6. Mark Kris (15)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Journal of Thoracic Oncology (11)
  3. Modern Pathology (6)
  4. Laboratory Investigation (5)
  5. Annals of Oncology (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Elsevier Inc. (15)
  3. Nature Publishing Group (8)
  4. Nature Research (6)
  5. American Association for Cancer Research (4)
  6. Oxford University Press (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
    Journal Article

    Scott, S. C.; Farago, A.; Lai, W. V.; Zahurak, M.; Rudek, M. A.; Murray, J.; Carducci, M. A.; Uziel, T.; Takebe, N.; Gore, S. D.; more...
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study
    Journal Article

    Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical benefit from immunotherapy in patients with SCLC is associated with tumor capacity for antigen presentation
    Journal Article

    Rudin, C. M.; Balli, D.; Lai, W. V.; Richards, A. L.; Nguyen, E.; Egger, J. V.; Choudhury, N. J.; Sen, T.; Chow, A.; Poirier, J. T.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: An open-label, phase I study
    Journal Article

    Paz-Ares, L.; Champiat, S.; Lai, W. V.; Izumi, H.; Govindan, R.; Boyer, M.; Hummel, H. D.; Borghaei, H.; Johnson, M. L.; Steeghs, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399
    Meeting Abstract

    Gentzler, R. D.; Piekarz, R.; Villaruz, L. C.; Rhee, J. C.; Lai, W. C. V.; Horton, B.; Mock, J.; Hanley, M.; Rudek, M. A.; Phelps, M. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
    Editorial

    Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save